Rhabdomyosarcoma of the biliary tract: a case report

Asmaa Kouadir, Abderrahmane El Mazghi, Khalid Hassouni


Rhabdomyosarcoma (RMS) of the biliary tract is a rare tumor that commonly arises from the common bile duct. The most common clinical symptoms are obstructive jaundice and abdominal pain. Although diagnosis is often difficult and is frequently made during surgery, diagnostic imaging techniques including ultrasound, computerized tomography scan, and magnetic resonance cholangiopancreatography remain useful in the diagnosis and evaluation of biliary tree anatomy. In order to improve prognosis, different rhabdomyosarcoma study groups have adopted multidisciplinary treatment approach. Herein we describe a case of three-year-old child with Embryonal rhabdomyosarcoma originating in the common bile duct who was treated with surgery, chemotherapy according to European soft tissue sarcoma group (EpSSG) protocol and adjuvant postoperative intensity modulated radiotherapy to surgical bed with 6 MV photons to a dose of 41, 4Gy in 23 fractions. One year and a half after the end of therapy, the patient is still disease free. Although Rhabdomyosarcoma of the biliary tract is a rare tumor, it should be considered in the differential diagnosis of patients who have obstructive jaundice and a cystic mass within the common bile duct. Once believed to be an incurable disease, the prognosis of patients with biliary rhabdomyosarcoma has improved with a multidisciplinary treatment approach.


Biliary tract, Common bile duct, EpSSG protocol, Rhabdomyosarcoma, Treatment approach

Full Text:



Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD, Arndt C, et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 2000;35:309-16.

Kebudi R, Gorgun O, Ayan I, Cosar R, Bilgic B. Rhabdomyosarcoma of the biliary tree. Pediatr Int. 2003;45:469-71.

Zampieri N, Camoglio F, Corroppolo M, Cecchetto M, Ornis S, Ottolenghi A. Botryoid rhabdomyosarcoma of the biliary tract in children: a unique case report. Eur J Cancer Care. 2006;15:463-6.

Ruymann FB, Raney RB, Crist WM, Lawrence W, Lindberg RD, Soule EH. Rhabdomyosarcoma of the biliary tree in childhood. A report from the intergroup rhabdomyosarcoma study. Cancer. 1985;56:575-81.

Chung EM, Lattin GE, Cube R, Lewis RB, Marichal-Hernandez C, Shawhan R, et al. From the archives of the AFIP: Pediatric liver masses: radiologic pathologic correlation Part2 Malignant tumors. Radiographics. 2011;31:483-507.

Morotti RA, Nicol KK, Parham DM, Teot LA, Moore J, Hayes J, et al. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the children’s oncology group experience. Am J Surg Pathol. 2006;30(8):962-8.

Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma. Seminars Pediatr Surg. 2016;25(5):276-83.

Eaton BR, Katzenstein HM, Sutter AL, Tighiouart M, Wasilewski-Masker K, Qayed K, et al. Delayed radiation therapy timing and use of intensity-modulated radiation therapy in non-head and neck pediatric rhabdomyosarcoma. J Radiat Oncol. 2013;2:71-7.

Dantonello TM, Stark M, Timmermann B, Fuchs J, Selle B, Linderkamp C, et al. Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatr Blood Cancer. 2015;62(1):16-23.

Terezakis SA, Wharam MD. Radiotherapy for rhabdomyosarcoma: indications and outcome. Clin Oncol. 2013;25:27-35.